Apimeds Pharmaceuticals US (APUS) Cash from Operations (2024 - 2025)
Apimeds Pharmaceuticals US (APUS) posted Cash from Operations of 3818202.0 for Q4 2025, down 121.2% on a QoQ basis from 1726166.0 in Q3 2025, and down 3732.92% year-over-year from 105100.07 in Q4 2024.
Apimeds Pharmaceuticals US (APUS) Cash from Operations (2024 - 2025) Analysis & Trends
Apimeds Pharmaceuticals US's Cash from Operations history runs 2 years deep, the most recent figure standing at 3818202.0 for Q4 2025.
- Quarterly Cash from Operations fell 3732.92% year-over-year to 3818202.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 8925777.0 (down 1116.83% YoY) and the FY2025 annual result came in at 8925777.0, down 1116.83% from the prior year.
- Cash from Operations was 3818202.0 for Q4 2025 at Apimeds Pharmaceuticals US, down from 1726166.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 20313.0 in Q1 2025 and bottomed at 3818202.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | Apimeds Pharmaceuticals US | 8.17 Mn | 8.17 Mn | - | -3.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.82 Mn |
| Dec 31, 2025 | -3.82 Mn |
| Sep 30, 2025 | -1.73 Mn |
| Sep 30, 2025 | -1.73 Mn |
| Jun 30, 2025 | -3.36 Mn |
| Jun 30, 2025 | -3.36 Mn |
| Mar 31, 2025 | -20,313.00 |
| Mar 31, 2025 | -20,313.00 |
| Dec 31, 2024 | -99,616.00 |
| Dec 31, 2024 | -99,616.00 |
| Sep 30, 2024 | -186,755.00 |
| Sep 30, 2024 | -186,755.00 |
| Jun 30, 2024 | -184,055.00 |
| Jun 30, 2024 | -184,055.00 |
| Mar 31, 2024 | -263,100.00 |
| Mar 31, 2024 | -263,100.00 |